The N-terminal sequences (5-20) of thymosin beta 4 binds to monomeric actin in an alpha-helical conformation.
Feinberg. J J; Heitz. F F; Benyamin. Y Y; Roustan. C C
Key Findings
- The peptide is unstructured in plain solution.
- Adding up to 30% TFE makes the peptide adopt an alpha‑helical shape.
- The helical form binds monomeric actin about ten times stronger than the unstructured form.
Practical Outcomes
- This finding is mainly of interest for lab work and doesn’t give a clear way to use thymosin‑beta‑4 fragments in humans. It suggests that the peptide’s activity depends on its shape, but no dosing or delivery method for biohackers is provided.
Summary
The study shows that a short piece of the protein thymosin‑beta‑4 (amino acids 5‑20) is floppy in water but folds into a helix when mixed with a lab chemical called TFE, and this folded shape sticks to single actin molecules much better. The chemical doesn’t change actin itself.
Abstract
The relationship between the conformation of a peptide in solution and its interaction capacity is generally unclear. Trifluoroethanol (TFE), which stabilizes alpha-helical conformations, can be used to induce definite folding in synthetic peptides. The N-terminal part of thymosin beta 4, including the 5-20 sequences, is implicated in binding to monomeric actin. The corresponding peptide was synthesized and its conformation studied by CD. The peptide is unstructured in solution, and becomes folded at medium TFE concentrations, below 30%. In contrast, TFE does not significantly modify the conformation of monomeric actin which conserves its intrinsic properties, such as gelsolin interaction and DNase-I inactivation. We report here that the apparent affinity of the synthetic peptide to monomeric actin is increased by an order of magnitude in the presence of TFE, which implies that the peptide adopts a folded conformation needed for accurate interaction.
Study Information
pubmed
1996
1996-05-06T00:00:00.000Z
10.1006/bbrc.1996.0709